Socio-economic burden of disease: survivorship costs for renal cell carcinoma
Objective The objective of this study is to assess the risk-stratified 10-year socio-economic burden of renal cell carcinoma (RCC) follow-up costs after initial treatment in Germany from 2000 to 2020. Methods A micro-costing method considering direct and indirect medical expenditure associated with...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2022
|
| In: |
European journal of cancer care
Year: 2022, Jahrgang: 31, Heft: 3, Pages: 1-11 |
| ISSN: | 1365-2354 |
| DOI: | 10.1111/ecc.13569 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ecc.13569 Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1111/ecc.13569 
|
| Verfasserangaben: | Julia Caroline Michaeli, Daniel Tobias Michaeli, Tobias Boch, Sebastian Albers, Thomas Michaeli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1881652157 | ||
| 003 | DE-627 | ||
| 005 | 20240312104620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ecc.13569 |2 doi | |
| 035 | |a (DE-627)1881652157 | ||
| 035 | |a (DE-599)KXP1881652157 | ||
| 035 | |a (OCoLC)1425215362 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michaeli, Julia |d 1996- |e VerfasserIn |0 (DE-588)127911424X |0 (DE-627)1832296377 |4 aut | |
| 245 | 1 | 0 | |a Socio-economic burden of disease: survivorship costs for renal cell carcinoma |c Julia Caroline Michaeli, Daniel Tobias Michaeli, Tobias Boch, Sebastian Albers, Thomas Michaeli |
| 264 | 1 | |c May 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Erstmals veröffentlicht: 15. März 2022 | ||
| 500 | |a Gesehen am 27.02.2024 | ||
| 520 | |a Objective The objective of this study is to assess the risk-stratified 10-year socio-economic burden of renal cell carcinoma (RCC) follow-up costs after initial treatment in Germany from 2000 to 2020. Methods A micro-costing method considering direct and indirect medical expenditure associated with follow-up procedures was employed to calculate survivorship costs per patient. The frequencies of physician-patient visits, examinations and diagnostic tests were extracted from guidelines, whilst expenses were sourced from literature and official scales of tariffs. Societal costs were calculated based on three perspectives: patients, providers and insurers. Results Mean societal 10-year follow-up costs per patient amounted to EUR 3,377 (95%CI: 2,969-3,791) for low-risk, EUR 3,367 (95%CI: 3,003-3,692) for medium-risk and EUR 4,299 (95%CI: 3,807-4,755) for high-risk RCC in 2020. Spending increased by +32% from 2000 to 2020 for low-risk RCC, whilst medium-and high-risk RCC expenditure was cut by −39% and −22%, respectively. Patients shouldered 27%, providers 43% and insurers 35% of costs in 2020. Resources were consumed by medical imaging (52%), physician-patient consultations (31%), travel expenses (17%) and blood tests (1%). Conclusion Results highlight the economic burden cancer survivorship poses for society. Cancer survivors require individualised, evidence-based and insurance-covered follow-up schedules to permit the early detection of side-effects, metastasis and secondary malignancies. | ||
| 650 | 4 | |a cancer survivors | |
| 650 | 4 | |a cost of illness | |
| 650 | 4 | |a health expenditure | |
| 650 | 4 | |a health insurance | |
| 650 | 4 | |a renal cell carcinoma | |
| 650 | 4 | |a survivorship | |
| 700 | 1 | |a Michaeli, Daniel |d 1997- |e VerfasserIn |0 (DE-588)1277183244 |0 (DE-627)1830345109 |4 aut | |
| 700 | 1 | |a Boch, Tobias |d 1984- |e VerfasserIn |0 (DE-588)1052922015 |0 (DE-627)789313847 |0 (DE-576)40866732X |4 aut | |
| 700 | 1 | |a Albers, Sebastian |d 1991- |e VerfasserIn |0 (DE-588)1258831201 |0 (DE-627)1805362208 |4 aut | |
| 700 | 1 | |a Michaeli, Christoph T. |d 1992- |e VerfasserIn |0 (DE-588)1277182337 |0 (DE-627)1830343769 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer care |d [Hoboken, NJ] : Wiley, 1992 |g 31(2022), 3 vom: Mai, Artikel-ID e13569, Seite 1-11 |h Online-Ressource |w (DE-627)320601536 |w (DE-600)2020234-9 |w (DE-576)091143489 |x 1365-2354 |7 nnas |a Socio-economic burden of disease: survivorship costs for renal cell carcinoma |
| 773 | 1 | 8 | |g volume:31 |g year:2022 |g number:3 |g month:05 |g elocationid:e13569 |g pages:1-11 |g extent:11 |a Socio-economic burden of disease: survivorship costs for renal cell carcinoma |
| 856 | 4 | 0 | |u https://doi.org/10.1111/ecc.13569 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/abs/10.1111/ecc.13569 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240227 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1277182337 |a Michaeli, Christoph T. |m 1277182337:Michaeli, Christoph T. |d 60000 |d 63600 |e 60000PM1277182337 |e 63600PM1277182337 |k 0/60000/ |k 1/60000/63600/ |p 5 |y j | ||
| 998 | |g 1258831201 |a Albers, Sebastian |m 1258831201:Albers, Sebastian |d 60000 |e 60000PA1258831201 |k 0/60000/ |p 4 | ||
| 998 | |g 1052922015 |a Boch, Tobias |m 1052922015:Boch, Tobias |d 60000 |d 61200 |e 60000PB1052922015 |e 61200PB1052922015 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 1277183244 |a Michaeli, Daniel |m 1277183244:Michaeli, Daniel |d 60000 |e 60000PM1277183244 |k 0/60000/ |p 2 | ||
| 998 | |g 127911424X |a Michaeli, Julia |m 127911424X:Michaeli, Julia |d 60000 |e 60000PM127911424X |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1881652157 |e 4491724857 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"May 2022","dateIssuedKey":"2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Socio-economic burden of disease: survivorship costs for renal cell carcinoma","title":"Socio-economic burden of disease: survivorship costs for renal cell carcinoma"}],"person":[{"role":"aut","display":"Michaeli, Julia","family":"Michaeli","given":"Julia"},{"role":"aut","display":"Michaeli, Daniel","given":"Daniel","family":"Michaeli"},{"family":"Boch","given":"Tobias","display":"Boch, Tobias","role":"aut"},{"role":"aut","display":"Albers, Sebastian","family":"Albers","given":"Sebastian"},{"role":"aut","family":"Michaeli","given":"Christoph T.","display":"Michaeli, Christoph T."}],"note":["Erstmals veröffentlicht: 15. März 2022","Gesehen am 27.02.2024"],"relHost":[{"pubHistory":["1.1992-"],"title":[{"title_sort":"European journal of cancer care","title":"European journal of cancer care"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Wiley ; Blackwell ; Wiley-Blackwell ; Hindawi Limited","dateIssuedDisp":"2024-","publisherPlace":"[Hoboken, NJ] ; Oxford [u.a.] ; Oxford [u.a.] ; London","dateIssuedKey":"2024"}],"note":["Gesehen am 31.01.2025","Fortsetzung der Druck-Ausgabe"],"recId":"320601536","id":{"doi":["10.1111/(ISSN)1365-2354"],"zdb":["2020234-9"],"issn":["1365-2354"],"eki":["320601536"]},"part":{"pages":"1-11","volume":"31","extent":"11","issue":"3","year":"2022","text":"31(2022), 3 vom: Mai, Artikel-ID e13569, Seite 1-11"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Socio-economic burden of disease: survivorship costs for renal cell carcinomaEuropean journal of cancer care","language":["eng"]}],"name":{"displayForm":["Julia Caroline Michaeli, Daniel Tobias Michaeli, Tobias Boch, Sebastian Albers, Thomas Michaeli"]},"id":{"eki":["1881652157"],"doi":["10.1111/ecc.13569"]},"recId":"1881652157","language":["eng"],"physDesc":[{"extent":"11 S."}]} | ||
| SRT | |a MICHAELIJUSOCIOECONO2022 | ||